Literature DB >> 23528942

Evaluation of hepatic steatosis in dogs with congenital portosystemic shunts using Oil Red O staining.

G B Hunt1, J A Luff, L Daniel, R Van den Bergh.   

Abstract

The aims of this prospective study were to quantify steatosis in dogs with congenital portosystemic shunts (CPS) using a fat-specific stain, to compare the amount of steatosis in different lobes of the liver, and to evaluate intra- and interobserver variability in lipid point counting. Computer-assisted point counting of lipid droplets was undertaken following Oil Red O staining in 21 dogs with congenital portosystemic shunts and 9 control dogs. Dogs with congenital portosystemic shunts had significantly more small lipid droplets (<6 μ) than control dogs (P = .0013 and .0002, respectively). There was no significant difference in steatosis between liver lobes for either control dogs and CPS dogs. Significant differences were seen between observers for the number of large lipid droplets (>9 μ) and lipogranulomas per tissue point (P = .023 and .01, respectively). In conclusion, computer-assisted counting of lipid droplets following Oil Red O staining of liver biopsy samples allows objective measurement and detection of significant differences between dogs with CPS and normal dogs. This method will allow future evaluation of the relationship between different presentations of CPS (anatomy, age, breed) and lipidosis, as well as the impact of hepatic lipidosis on outcomes following surgical shunt attenuation.

Entities:  

Keywords:  congenital portosystemic shunt; dog; liver; steatosis

Mesh:

Substances:

Year:  2013        PMID: 23528942      PMCID: PMC4445129          DOI: 10.1177/0300985813481609

Source DB:  PubMed          Journal:  Vet Pathol        ISSN: 0300-9858            Impact factor:   2.221


  29 in total

1.  Hepatic volume measurements in dogs with extrahepatic congenital portosystemic shunts before and after surgical attenuation.

Authors:  A Kummeling; D J E Vrakking; J Rothuizen; K M Gerritsen; F J van Sluijs
Journal:  J Vet Intern Med       Date:  2010 Jan-Feb       Impact factor: 3.333

2.  Hepatic lesions of a standard poodle dog with intrahepatic portosystemic shunt.

Authors:  Kaori Isobe; Satoru Matsunaga; Hiroyuki Nakayama; Koji Uetsuka
Journal:  J Vet Med Sci       Date:  2008-10       Impact factor: 1.267

3.  Severe steatosis increases hepatocellular injury and impairs liver regeneration in a rat model of partial hepatectomy.

Authors:  Reeta Veteläinen; Arlène K van Vliet; Thomas M van Gulik
Journal:  Ann Surg       Date:  2007-01       Impact factor: 12.969

4.  Histopathological and immunohistochemical investigations of hepatic lesions associated with congenital portosystemic shunt in dogs.

Authors:  S Baade; H Aupperle; V Grevel; H-A Schoon
Journal:  J Comp Pathol       Date:  2006-01       Impact factor: 1.311

5.  Mouse livers with macrosteatosis are more susceptible to normothermic ischemic injury than those with microsteatosis.

Authors:  Nazia Selzner; Markus Selzner; Wolfram Jochum; Beatrice Amann-Vesti; Rolf Graf; Pierre-Alain Clavien
Journal:  J Hepatol       Date:  2005-09-02       Impact factor: 25.083

6.  Vacuolar hepatopathy in dogs: 336 cases (1993-2005).

Authors:  Lisa M Sepesy; Sharon A Center; John F Randolph; Karen L Warner; Hollis N Erb
Journal:  J Am Vet Med Assoc       Date:  2006-07-15       Impact factor: 1.936

7.  Use of transcolonic portal scintigraphy to evaluate efficacy of cellophane banding of congenital extrahepatic portosystemic shunts in 16 dogs.

Authors:  B P Landon; L A Abraham; J A Charles
Journal:  Aust Vet J       Date:  2008-05       Impact factor: 1.281

8.  Histologic examination of hepatic biopsy samples as a prognostic indicator in dogs undergoing surgical correction of congenital portosystemic shunts: 64 cases (1997-2005).

Authors:  Jacquelyn S Parker; Eric Monnet; Barbara E Powers; David C Twedt
Journal:  J Am Vet Med Assoc       Date:  2008-05-15       Impact factor: 1.936

Review 9.  Hepatic microcirculation in fatty liver disease.

Authors:  Geoff C Farrell; N C Teoh; R S McCuskey
Journal:  Anat Rec (Hoboken)       Date:  2008-06       Impact factor: 2.064

10.  Histopathological characteristics of hepatic lipogranulomas with portosystemic shunt in dogs.

Authors:  Kaori Isobe; Satoru Matsunaga; Hiroyuki Nakayama; Koji Uetsuka
Journal:  J Vet Med Sci       Date:  2008-02       Impact factor: 1.267

View more
  6 in total

1.  Dietary blueberry and bifidobacteria attenuate nonalcoholic fatty liver disease in rats by affecting SIRT1-mediated signaling pathway.

Authors:  Tingting Ren; Chao Huang; Mingliang Cheng
Journal:  Oxid Med Cell Longev       Date:  2014-11-27       Impact factor: 6.543

2.  Histopathologic variation between liver lobes in dogs.

Authors:  S D Kemp; K L Zimmerman; D L Panciera; W E Monroe; M S Leib
Journal:  J Vet Intern Med       Date:  2015-01-12       Impact factor: 3.333

3.  Aberrant hepatic lipid storage and metabolism in canine portosystemic shunts.

Authors:  Lindsay Van den Bossche; Vivien A C Schoonenberg; Iwan A Burgener; Louis C Penning; Ingrid M Schrall; Hedwig S Kruitwagen; Monique E van Wolferen; Guy C M Grinwis; Anne Kummeling; Jan Rothuizen; Jeroen F van Velzen; Nikolas Stathonikos; Martijn R Molenaar; Bernd J Helms; Jos F H M Brouwers; Bart Spee; Frank G van Steenbeek
Journal:  PLoS One       Date:  2017-10-19       Impact factor: 3.240

4.  5-Bis-(2,6-difluoro-benzylidene) Cyclopentanone Acts as a Selective 11β-Hydroxysteroid Dehydrogenase one Inhibitor to Treat Diet-Induced Nonalcoholic Fatty Liver Disease in Mice.

Authors:  Hongguo Guan; Yiyan Wang; Huitao Li; Qiqi Zhu; Xiaoheng Li; Guang Liang; Ren-Shan Ge
Journal:  Front Pharmacol       Date:  2021-04-12       Impact factor: 5.810

5.  Hypolipogenic Effect of Shikimic Acid Via Inhibition of MID1IP1 and Phosphorylation of AMPK/ACC.

Authors:  Moon Joon Kim; Deok Yong Sim; Hye Min Lee; Hyo-Jung Lee; Sung-Hoon Kim
Journal:  Int J Mol Sci       Date:  2019-01-29       Impact factor: 5.923

Review 6.  Whole Slide Imaging and Its Applications to Histopathological Studies of Liver Disorders.

Authors:  Rossana C N Melo; Maximilian W D Raas; Cinthia Palazzi; Vitor H Neves; Kássia K Malta; Thiago P Silva
Journal:  Front Med (Lausanne)       Date:  2020-01-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.